Approval · Notice of Compliance 29960 · 2023
KENGREXAL: Notice of Compliance 29960
Issued January 20, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29960
- Date
- January 20, 2023
- Company
- Chiesi Farmaceutici S.P.A.Parma, Italy
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KENGREXAL | 02534622 | Marketed |
Medicinal ingredients
- CANGRELOR TETRASODIUM 50 MG per VIAL